Dr. David S. Dimarco, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Saint Louis University School of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 521
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Saint Louis University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
OR license MD26099
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sacred Heart Medical Center - Riverbend Springfield, OR
- Mercy Medical Center Roseburg, OR
- Peace Harbor Medical Center Florence, OR
- Mckenzie-Willamette Medical Center Springfield, OR
- Lower Umpqua Hospital District Reedsport, OR
Medical groups
- Oregon Urology Institute PC (34 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 521
- Services billed
- 7,222
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 988 | 12 |
| Established patient office or other outpatient visit, 30-39 minutes | 204 | 149 |
| Established patient office or other outpatient visit, 20-29 minutes | 189 | 162 |
| Urinalysis, manual test | 163 | 121 |
| Diagnostic exam of bladder and urethra using an endoscope | 114 | 94 |
| Complete ultrasound scan behind abdominal cavity | 106 | 70 |
| Ultrasound measurement of bladder capacity after voiding | 95 | 77 |
| Bacterial colony count, urine | 27 | 22 |
| Bacterial urine culture | 24 | 15 |
| Bacterial culture for aerobic isolates | 23 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 3 payments worth $393 in total to this clinician.
| Telix Pharmaceuticals | $205 |
|---|---|
| Dendreon Pharmaceuticals LLC | $157 |
| AstraZeneca Pharmaceuticals LP | $31.05 |
| Food and Beverage | $393 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $57,730 in research payments for these studies, mostly to the institutions running them.
- PEAK
Laborie Medical Technologies Corp.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.